帕金森病及相关运动障碍的神经影像学诊断专家共识

doi:10.16150/j.1671-2870.2018.04.009

诊断学理论与实践 ›› 2018, Vol. 17 ›› Issue (04): 403-408.doi: 10.16150/j.1671-2870.2018.04.009

帕金森病及相关运动障碍的神经影像学诊断专家共识

崔海伦^1a, 张一帆^1b, 管晓军^2a, 黄沛钰^2a, 刘志蓉^2b, 袁园³, 刘晓云⁴, 朱红灿⁵, 曹学兵⁶, 陈玲⁷, 陈先文⁸, 陈燕⁹, 商慧芳¹⁰, 杨任民¹¹, 陈生弟^1a, 张敏鸣^2a, 王刚^1a

1.上海交通大学医学院附属瑞金医院 a. 神经内科; b. 核医学科,上海 200025;
2.浙江大学医学院附属第二医院 a. 放射科 b. 神经内科,浙江杭州 310009;
3.浙江大学医学院附属第一医院神经内科,浙江杭州310003;
4.河北医科大学第二医院神经内科,河北石家庄 050000;
5.郑州大学第一附属医院神经内科,河南郑州 450052;
6.华中科技大学同济医学院附属协和医院神经内科,湖北武汉 430022）;
7.中山大学附属第一医院神经内科,广东广州 510080;
8.安徽医科大学第一附属医院神经内科,安徽合肥 230022;
9.山东省立医院神经内科,山东济南 250021;
10.四川大学附属华西医院神经内科,四川成都 610041;
11.安徽中医药大学神经病学研究所附属医院,安徽合肥 230061

收稿日期:2018-07-02 出版日期:2018-08-25 发布日期:2018-08-25
通讯作者: 王刚 E-mail: wg11424@rjh.com.cn;张敏鸣 E-mail: zhangminming@zju.edu.cn

Received:2018-07-02 Online:2018-08-25 Published:2018-08-25

摘要/Abstract

中图分类号:

R742

崔海伦, 张一帆, 管晓军, 黄沛钰, 刘志蓉, 袁园, 刘晓云, 朱红灿, 曹学兵, 陈玲, 陈先文, 陈燕, 商慧芳, 杨任民, 陈生弟, 张敏鸣, 王刚. 帕金森病及相关运动障碍的神经影像学诊断专家共识[J]. 诊断学理论与实践, 2018, 17(04): 403-408.

[1] 崔海伦, 任汝静, 王刚. 帕金森病及帕金森叠加综合征神经影像学诊断价值及研究进展[J]. 中国现代神经疾病杂志, 2018,18(4):231-237.
[2] 王刚, 吕发金. 痴呆及相关认知障碍的神经影像学诊断流程建议[J]. 重庆医科大学学报,2017,42(6):684-686.
[3] Manyam BV.What is and what is not 'Fahr's disease'[J]. Parkinsonism Relat Disord,2005,11(2):73-80.
[4] 黄越, 陈生弟, Gregor Wenning, 等. 非典型性帕金森样病[J]. 中国现代神经疾病杂志,2011,11(1):7-14.
[5] 崔诗爽, 陈生弟, 王刚. 非酮症性高血糖伴偏侧舞蹈症一例[J]. 中华神经科杂志,2017,50(1):54-55,56.
[6] Massey LA, Jäger HR, Paviour DC, et al.The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy[J]. Neurology,2013,80(20):1856-1861.
[7] Yoon RG, Kim SJ, Kim HS, et al.The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography[J]. Neurosci Lett,2015,584:296-301.
[8] Wang Y, Butros SR, Shuai X, et al.Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging[J]. Am J Neuroradiol, 2012,33(2):266-273.
[9] 金莉蓉, 黄振. 帕金森病磁共振成像研究进展[J]. 重庆医科大学学报, 2017,42(6):662-666.
[10] Madhyastha TM, Askren MK, Boord P, et al.Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease[J]. Mov Disord,2015, 30(14):1893-1900.
[11] Teune LK, Renken RJ, de Jong BM, et al. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET ima-ging[J]. Neuroimage Clin,2014,5:240-244.
[12] Melzer T, Watts R, MacAskill MR, et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease[J]. Brain,2011,134(Pt 3):845-855.
[13] Deng XY, Wang L, Yang TT, et al.A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease[J]. Sci Rep,2018,8(1):2941.
[14] 邢一兰, 陈俊抛, 苏欢欢. 磁共振弥散张量成像在帕金森病早期诊断以及定量分析中的临床应用价值[J]. 中国现代医学杂志, 2015,25(8):43-46.
[15] Vaillancourt DE, Spraker MB, Prodoehl J, et al.High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease[J]. Neurology,2009,72(16):1378-1384.
[16] Du G, Lewis MM, Sen S, et al.Imaging nigral pathology and clinical progression in Parkinson's disease[J]. Mov Disord,2012,27(13):1636-1643.
[17] Prakash BD, Sitoh YY, Tan LC, et al.Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease[J]. Parkinsonism Relat Disord,2012,18(9):1029-1033.
[18] Vaillancourt DE, Spraker MB, Prodoehl J, et al.High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease[J]. Neurology,2009,72(16):1378-1384.
[19] Gao LL, Wu T.The study of brain functional connectivity in Parkinson's disease[J]. Transl Neurodegener,2016, 5:18.
[20] Zang YF, He Y, Zhu CZ, et al.Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI[J]. Brain Dev,2007,29(2):83-91.
[21] Zang Y, Jiang T, Lu Y, et al.Regional homogeneity approach to fMRI data analysis[J]. Neuroimage,2004,22(1):394-400.
[22] Díez-Cirarda M, Strafella AP, Kim J, et al.Dynamic functional connectivity in Parkinson's disease patients with mild cognitive impairment and normal cognition[J]. Neuroimage Clin, 2018,17:847-855.
[23] 梅明金, 聂坤, 熊冬生, 等. 帕金森病多模态磁共振成像和基于图论的复杂网络分析法研究进展[J]. 中国现代神经疾病杂志,2017,17(1):14-17.
[24] Ciurleo R, Bonanno L, Di Lorenzo G, et al.Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study[J]. Neurosci Lett,2015,599:55-60.
[25] Guan J, Rong Y, Wen Y, et al.Detection and application of neurochemical profile by multiple regional (1)H-MRS in Parkinson's disease[J]. Brain Behav,2017,7(9):e00792.
[26] Federico F, Simone IL, Lucivero V, et al.Proton magne-tic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders[J]. Mov Disord,1997,12(6):903-909.
[27] Gröger A, Bender B, Wurster I, et al.Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging[J]. J Neurol Neurosurg Psychiatry,2013,84(6):644-649.
[28] Zanigni S, Testa C, Calandra-Buonaura G, et al.The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes[J]. Parkinsonism Relat Disord, 2015, 21(8):929-937.
[29] Yamamoto H, Arimura S, Nakanishi A, et al.Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT[J]. Ann Nucl Med, 2017, 31(5):407-412.
[30] Yoshii F, Ryo M, Baba Y, et al.Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease[J]. J Neurol Sci,2017, 375:80-85.
[31] Berg D, Behnke S, Seppi K, et al.Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease[J]. Mov Disord,2013,28(2):216-219.
[32] Berg D,Godau J, Walter U.Transcranial sonography in movement disorders[J]. Lancet Neurol,2008,7(11):1044-1055.
[33] Iranzo A, Stockner H, Serradell M, et al.Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder[J]. Mov Disord, 2014,29(14):1774-1780.
[34] Li DH, He YC, Liu J, et al.Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis[J]. Sci Rep,2016,6:20863.
[35] Walter U, Dressler D, Probst T, et al.Transcranial brain sonography findings in discriminating between parkinso-nism and idiopathic Parkinson disease[J]. Arch Neurol,2007,64(11):1635-1640.
[36] Giannoccaro MP, Donadio V, Incensi A, et al.Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: a comparative study[J]. Mov Disord,2015,30(7):986-989.
[37] Mochizuki H, Ebihara Y, Ugawa Y, et al.PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease[J]. Eur Neurol,2015,74(1-2):107-111.
[38] Sakakibara R, Tateno F, et al.MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review[J]. Parkinsonism Relat Disord,2014,20(3):267-273
[39] Nicastro N, Burkhard PR, Garibotto V.Scan without evidence of dopaminergic deficit(SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study[J]. J Neurol Sci,2018,385:17-21.
[40] Erro R, Bhatia KP.Novel movement disorder society-Parkinson's disease criteria: What about SWEDD and genetic forms?[J]. Mov Disord,2016,31(3):431.

帕金森病及相关运动障碍的神经影像学诊断专家共识

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	何亲羽, 王伟, 陈立芬, 张雪蕾, 董治亚. LHCGR基因突变致家族性男性性早熟2例报告及文献复习[J]. 诊断学理论与实践, 2022, 21(05): 598-605.
[2]	武冬冬, 陈玉辉, 刘芳, 刘银红, 蒋景文. 脑小血管疾病合并中枢神经系统退行性疾病机制的研究进展[J]. 诊断学理论与实践, 2022, 21(05): 644-649.
[3]	陈志敏, 何浩岚. 艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[4]	沈银忠. 《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[5]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[6]	何新, 陈慧, 冯炜炜. 机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[7]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊. 实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[8]	赵然, 詹维伟, 侯怡卿. 计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[9]	郭业兵, 郑金峰. 阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[10]	王刚, 陈生弟. 神经病学的诊断：起源、发展及挑战[J]. 诊断学理论与实践, 2022, 21(01): 1-4.
[11]	唐静仪, 余群, 刘军. 结合人工智能的结构影像分析对阿尔茨海默病的早期预测及精准诊断研究进展[J]. 诊断学理论与实践, 2022, 21(01): 12-17.
[12]	魏文石. 直面我国阿尔茨海默病诊治的挑战——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 5-7.
[13]	王蔚, 王小钦. 缺铁性贫血的病因诊断[J]. 诊断学理论与实践, 2021, 20(06): 529-532.
[14]	岳婧婧, 宋琦, 江旭峰, 王黎, 赵维莅, 严福华. 磁共振全身扩散加权成像结合T2WI抑脂序列与FDG-PET/CT在初发淋巴瘤分期及病灶检出的对比研究[J]. 诊断学理论与实践, 2021, 20(06): 540-546.
[15]	王昭晖, 吴海波. 胃神经鞘瘤31例临床病理学分析[J]. 诊断学理论与实践, 2021, 20(06): 552-556.